Maternus-Kliniken AGHAM:MAK -8.76%41 Days Payable is 101.41 as of Dec. 2025, which is 10% below its 10-year median of 113.18. GuruFocus rates HAM:MAK with a GF Score™ of 41/100 and a GF Value™ of €1.97 (Possible Value Trap). The stock has 4 warning signs investors should review. Among 606 Healthcare Providers & Services companies, Maternus-Kliniken AG ranks better than 72.94% on this metric.
The historical rank and industry rank for Maternus-Kliniken AG's Days Payable or its related term are showing as below:
HAM:MAK'
s Days Payable Range Over the Past 10 Years
Min: 83.33 Med: 113.18 Max: 152.25
Current: 113.13
During the past 13 years, Maternus-Kliniken AG's highest Days Payable was 152.25. The lowest was 83.33. And the median was 113.18.
HAM:MAK's Days Payable is ranked better than 72.94% of 606
companies
in the Healthcare Providers & Services industry
Industry Median: 58.205
vs HAM:MAK: 113.13
Maternus-Kliniken AG's Days Payable
increased
from Dec. 2024 (99.27) to Dec. 2025 (101.41).
It may suggest that Maternus-Kliniken AGdelayed paying its suppliers.
Maternus-Kliniken AG Days Payable Related Terms
Maternus-Kliniken AG Days Payable Historical Data
* Premium members only.
The historical data trend for Maternus-Kliniken AG's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Maternus-Kliniken AG's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Maternus-Kliniken AG Days Payable vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Maternus-Kliniken AG's Days Payable distribution charts can be found below:
* The bar in red indicates where Maternus-Kliniken AG's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Maternus-Kliniken AG's Days Payable for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Maternus-Kliniken AG (HAM:MAK) has a Days Payable of 101.41 as of Dec. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Maternus-Kliniken AG and its competitors. This is 10% below median its historical median of 113.18. Over the past decade, Maternus-Kliniken AG's Days Payable has ranged from 83.33 to 152.25. According to the industry distribution chart, Maternus-Kliniken AG ranks #164 out of 606 companies in the Healthcare Providers & Services industry, placing it in the top 27.1%.
Is Maternus-Kliniken AG's Days Payable too high?
Maternus-Kliniken AG's current Days Payable of 101.41 is 10% below median its 10-year median of 113.18. Over the past 10 years, this metric has ranged from a low of 83.33 to a high of 152.25. The Healthcare Providers & Services industry median Days Payable is 58.21. Maternus-Kliniken AG's value of 101.41 is 74.2% above this industry median. Based on the distribution chart, Maternus-Kliniken AG ranks #164 out of 606 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Maternus-Kliniken AG has a GF Score™ of 41/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Maternus-Kliniken AG's Days Payable compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Maternus-Kliniken AG ranks #164 out of 606 companies for Days Payable. This puts Maternus-Kliniken AG in the upper half of its industry. The industry median Days Payable is 58.21. Maternus-Kliniken AG's value of 101.41 is 74.2% above this benchmark. Historically, Maternus-Kliniken AG's own Days Payable has ranged from 83.33 to 152.25 over the past decade. While the company's 10-year median is 113.18 vs. the industry median of 58.21, Maternus-Kliniken AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Healthcare Providers & Services company?
The median Days Payable among Healthcare Providers & Services companies is 58.21, based on 606 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Maternus-Kliniken AG's current Days Payable of 101.41 is 74.2% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Maternus-Kliniken AG and its competitors. For the Healthcare Providers & Services industry, the median Days Payable is 58.21 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Maternus-Kliniken AG's current Days Payable is 101.41, which is 10% below median its own 10-year median of 113.18. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Maternus-Kliniken AG stock overvalued right now?
Based on GuruFocus' analysis, Maternus-Kliniken AG (HAM:MAK) is currently considered Possible Value Trap. The stock's GF Value™ is €1.97, compared to a current price of €0.89 — trading 55.1% below its estimated fair value. The current Days Payable is 101.41, which is 10% below median its 10-year median of 113.18 and 74.2% above the Healthcare Providers & Services industry median of 58.21. Maternus-Kliniken AG's overall GF Score™ is 41/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Maternus-Kliniken AG (HAM:MAK), the current Days Payable is 101.41 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Maternus-Kliniken AG (HAM:MAK) Overvalued in 2026?
Based on GuruFocus' analysis, Maternus-Kliniken AG stock appears to be undervalued.
The current stock price of €0.89 is trading 55.1% below its estimated GF Value™ of €1.97.
GuruFocus considers Maternus-Kliniken AG to be Possible Value Trap.
Key valuation signals for HAM:MAK:
Days Payable: 101.41 (10% below median its 10-year median of 113.18)
GF Value™: €1.97 vs. price of €0.89 (55.1% below fair value)
Industry Position: 74.2% above the Healthcare Providers & Services median (#164 of 606)
No single metric tells the full story. See the HAM:MAK stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HAM:MAK has been successfully added to your 
